Gregory Feldman
- Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation, in COPDBy Marc Decramer, Francois Maltais, Gregory Feldman, Jean Brooks, Lisa Willits, Stephanie Harris and Glenn CraterMarc Decramer1Respiratory Division, University Hospital, University of Leuven, Leuven, BelgiumFrancois Maltais2Institut Universitaire de Cardiologie et de Pneumologie, Faculté de Médecine, Université Laval, Laval, CanadaGregory Feldman3Research, S. Carolina Pharmaceutical, Spartanburg, United StatesJean Brooks4Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, United KingdomLisa Willits5Respiratory Medicines Development Centre S&P, GlaxoSmithKline, Uxbridge, United KingdomStephanie Harris6Medicines Development Centre, GlaxoSmithKline, Rearch Triangle Park, United StatesGlenn Crater7Respiratory and Immuno-Inflammation Medicine Development Center, GlaxoSmithKline, Rearch Triangle Park, United States
- Lung function effects and safety of fluticasone furoate (FF)/vilanterol (VI) in patients with COPD: Mid-high dose assessmentBy Fernando Martinez, Joseph Boscia, Gregory Feldman, Catherine Scott-Wilson, Sally Kilbride, Leonardi Fabbri, Peter M.A. Calverley and Courtney CrimFernando Martinez1Department of Medicine, University of Michigan, Ann Arbor, United StatesJoseph Boscia2Clinical Research, CU Pharmaceutical Research, Union, United StatesGregory Feldman3Clinical Research, S. Carolina Pharmaceutical Research, Spartanburg, United StatesCatherine Scott-Wilson4Respiratory Medicine Development Center, GlaxoSmithKline, Research Triangle Park, United KingdomSally Kilbride5Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyLeonardi Fabbri6Clinical Science Centre, University Hospital Aintree, Liverpool, United KingdomPeter M.A. Calverley6Clinical Science Centre, University Hospital Aintree, Liverpool, United KingdomCourtney Crim4Respiratory Medicine Development Center, GlaxoSmithKline, Research Triangle Park, United Kingdom
- Lung function efficacy of olodaterol QD delivered via Respimat® in COPD patients: Results from two 48-week studiesBy Gary Ferguson, Gregory Feldman, Peter Hofbauer, Alan Hamilton, Lisa Allen, Lawrence Korducki and Paul SachsGary Ferguson1Pulmonary Research Institute of Southeast Michigan, Livonia, MI, United StatesGregory Feldman2South Carolina Pharmaceutical Research, Spartanburg, SC, United StatesPeter Hofbauer3Pneumologie-Weinheim, Weinheim, GermanyAlan Hamilton4Boehringer Ingelheim, Burlington, ON, CanadaLisa Allen5Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesLawrence Korducki5Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesPaul Sachs6Pulmonary Associates of Stamford, Stamford, CT, United States
- Induction of neutrophil extracellular traps (NETs) by the pneumococcal toxin, pneumolysin (Ply)By Jan-Gert Nel, Annette Theron, Chrisna Durandt, Gregory Tintinger, Roger Pool, Timothy Mitchell, Ronald Anderson and Charles FeldmanJan-Gert Nel1Department of Haematology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, Gauteng South AfricaAnnette Theron2Department of Immunology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, Gauteng South AfricaChrisna Durandt3Institute of Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, Gauteng South AfricaGregory Tintinger4Department of Internal Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, Gauteng South AfricaRoger Pool1Department of Haematology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, Gauteng South AfricaTimothy Mitchell5School of Immunology and Infection, College of Medicine and Dental Sciences, University of Brimingham, Birmingham, United KingdomRonald Anderson3Institute of Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, Gauteng South AfricaCharles Feldman6Division of Pulmonology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng South Africa
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.